CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
Leung KT, Zhang C, Chan KYY, Li K, Cheung JTK, Ng MHL, Zhang XB, Sit T, Lee WYW, Kang W, To KF, Yu JWS, Man TKF, Wang H, Tsang KS, Cheng FWT, Lam GKS, Chow TW, Leung AWK, Leung TF, Yuen PMP, Ng PC, Li CK.
Leung KT, et al. Among authors: tsang ks.
Leukemia. 2020 Mar;34(3):709-720. doi: 10.1038/s41375-019-0593-7. Epub 2019 Oct 17.
Leukemia. 2020.
PMID: 31624373